IPO Trending
CONCORDBIOEQ / NSE, BSEListed
Concord Biotech

Incorporated in 1984, Concord Biotech Limited is an India-based biopharmaceutical company and a leading global developer and manufacturer of fermentation-based APIs, specializing in immunosuppressants and oncology. The company has a strong global presence, supplying products to over 70 countries including the USA, India, Europe, and Japan. Concord Biotech manufactures Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, along with finished formulations. Starting with a single product, the company has expanded to offer a broad spectrum of biopharma solutions, establishing itself as a key player in the global API market.

₹705 - ₹74126.13x sub
Listed Price₹900.05
Listing Gain+21.46%

IPO Schedule & Timeline

Book Built Issue IPO
Open04 Aug 2023
Close08 Aug 2023
Allotment14 Aug 2023
Listing18 Aug 2023

Quota Reservation & Application Lots

Quota Reservation (% Shares)

QIB1,04,57,825 shares
49.98%
Nii (hni)31,37,348 shares
14.99%
Retail73,20,479 shares
34.98%
Employee10,000 shares
0.05%

Minimum Application Lots

Retail1 Lot (20 shares)
₹14,820
sHNI14 Lots (280 shares)
₹2,07,480
bHNI68 Lots (1,360 shares)
₹10,07,760

Company Promoters

Mr. Sudhir VaidMr. Ankur Vaid

Company Background

Incorporated in 1984, Concord Biotech Limited is an India-based biopharmaceutical company and a leading global developer and manufacturer of fermentation-based APIs, specializing in immunosuppressants and oncology. The company has a strong global presence, supplying products to over 70 countries including the USA, India, Europe, and Japan. Concord Biotech ma...

Financial Performance

Figures in ₹ Crores
Metric Breakdown

Revenue

Latest (31 Mar 2021)₹630.75 Cr
Growth-29.0%
Revenue Trend (₹ in Crores)
0.0340.6681.21.0k31 Mar 202331 Mar 202231 Mar 2021
PeriodRev (Cr)PAT (Cr)AssetsDebt
31 Mar 2021630.75234.891,182.5586.35
31 Mar 2022736.35174.931,312.8060.59
31 Mar 2023888.48240.081,513.9831.24

Key Performance Indicators (KPIs)

PeriodEPSROEROCEP/E (Pre)P/E (Post)
Values20.7920.06%24.27%32.290

Broker & Analyst Reviews

Review Not Available

Institutional broker reviews and analyst reports have not been released for this issue yet. Reviews are typically published 2 to 3 days prior to the issue opening date.

IPO Allotment & Registrar Status

Official Registrar: Link Intime India Private Limited

Allotment Finalized
Allotment Date
14 Aug 2023
Official Status
Out / Finalized
Registrar
Link Intime India Private Limited
Listing Date
18 Aug 2023

Official Allotment Verification Links

Official Registrar Portal
Link Intime India Private Limited

Direct allotment verification on the official registrar portal appointed for Concord Biotech. Check with PAN or Application No.

Check on Registrar Portal
Stock Exchange Portal
BSE India Investor Portal

Official Bombay Stock Exchange investor verification channel using Issue Name and PAN Number.

Check on BSE India

Allotment Schedule & Milestones

IST
1. Allotment Finalization14 Aug 2023Basis of allotment declared
2. Refund Initiation1 day post allotmentUPI / ASBA mandate unblocked
3. Demat CreditPrior to listingShares credited to CDSL/NSDL
4. Listing Date18 Aug 2023Trading commences on exchange

How to Check Concord Biotech Allotment Online

1Open Portal

Click on the official registrar link or BSE portal button above.

2Select Company

Select Concord Biotech from the issue drop-down list.

3Enter Details

Select PAN, Application No., or DP Client ID and type your details.

4View Allocation

Click Submit to check your allotted share count and status.

Prospectus & Official Filings

Allotment FAQs & Help

About Concord Biotech IPO

Complete issue overview for Concord Biotech (CONCORDBIO) IPO. The issue features an equity share price band of ₹705 – ₹741 per share with a minimum retail lot size of 20 Shares (minimum application amount of ₹14,820). Explore live market tracking on our GMP Tracker, compare against All IPO GMP Today, or view category bidding on the Subscription Page. Verify official allotment via IPO Registrars or review participating investment bankers in our Lead Managers Directory.

Frequently Asked Questions